GLAXOSMITHKLINE CEO SAYS NOT SURE A SINGLE NARRATIVEAROUND SECTOR M&AGLAXOSMITHKLINE CEO SAYS NO UPDATE ON CHINAINVESTIGATIONGLAXOSMITHKLINE CEO SAYS U.S. ADVAIR SHARE FELL IN EARLYJANUARY BUT HAS SINCE STABILISEDGLAXOSMITHKLINE CEO SAYS UK HAS "TERRIFIC" SCIENCE BASEAND GREAT SUPPORT FOR INVESTMENT VIA PATENT BOXGLAXOSMITHKLINE CEO, ASKED ABOUT PFIZER, SAYS HOPESRATIONAL PEOPLE WILL CHOOSE TO INVEST IN UKGLAXOSMITHKLINE CEO DECLINES TO COMMENT ON POTENTIALINTEREST IN ASTRAZENECA BUT SAYS WON'T BE DISTRACTED FROM ITSCORE R&D BUSINESSGLAXOSMITHKLINE CEO SAYS MAY DISPOSE OF INDIVIDUALESTABLISHED DRUGS OR BROADER PORTFOLIO OF PRODUCTSGLAXOSMITHKLINE CEO SAYS PREFERS TO DO VERY TARGETEDTRANSACTIONSGLAXOSMITHKLINE CEO SAYS TARGETED DEALS DIFFICULT,SOMETIMES THE TRADITIONAL APPROACH TO M&A IS EASIERGLAXOSMITHKLINE CEO SAYS BROAD-SCALE TRANSACTIONS"DISTRACTING"
LONDON MARKET OPEN: Stocks lack direction ahead of Fed, BoE
(Alliance News) - Stock prices in London lacked direction at the open on Wednesday, as investors nervously look ahead to interest rate decisions from the US Federal Reserve and Bank of England.
Read more